Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Arvaya Healthcare's annualized net income for the quarter that ended in Mar. 2026 was ₹50.65 Mil. Arvaya Healthcare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹315.61 Mil. Therefore, Arvaya Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 16.05%.
The historical rank and industry rank for Arvaya Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
BOM:524723'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -11.9 Med: -2.34 Max: 4
Current: 3.72
During the past 13 years, Arvaya Healthcare's highest Return-on-Tangible-Equity was 4.00%. The lowest was -11.90%. And the median was -2.34%.
BOM:524723's Return-on-Tangible-Equity is ranked worse than 72.07% of 111
companies
in the Medical Distribution industry
Industry Median: 8.78
vs BOM:524723: 3.72
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Arvaya Healthcare Return-on-Tangible-Equity Related Terms
Arvaya Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 16.05% mean?
Arvaya Healthcare (BOM:524723) has a Return-on-Tangible-Equity of 16.05% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Arvaya Healthcare and its competitors. According to the industry distribution chart, Arvaya Healthcare ranks #80 out of 111 companies in the Medical Distribution industry, placing it in the top 72.1%.
Is Arvaya Healthcare's Return-on-Tangible-Equity too high?
Arvaya Healthcare's current Return-on-Tangible-Equity is 16.05%. The Medical Distribution industry median Return-on-Tangible-Equity is 8.78. Arvaya Healthcare's value of 16.05% is 82.8% above this industry median. Based on the distribution chart, Arvaya Healthcare ranks #80 out of 111 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Arvaya Healthcare has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #80 out of 111 companies for Return-on-Tangible-Equity. This places Arvaya Healthcare in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.78. Arvaya Healthcare's value of 16.05% is 82.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.78, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current Return-on-Tangible-Equity of 16.05% is 82.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current Return-on-Tangible-Equity is 16.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹49.82, compared to a current price of ₹131.58 — trading 164.1% above its estimated fair value. The current Return-on-Tangible-Equity is 16.05% and 82.8% above the Medical Distribution industry median of 8.78. Arvaya Healthcare's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Return-on-Tangible-Equity is 16.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹131.58 is trading 164.1% above its estimated GF Value™ of ₹49.82.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
Return-on-Tangible-Equity: 16.05%
GF Value™: ₹49.82 vs. price of ₹131.58 (164.1% above fair value)
Industry Position: 82.8% above the Medical Distribution median (#80 of 111)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
36GF Score
Get the complete analysis for BOM:524723
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
